Purchase this article with an account.
T. M. Dzhusoev, Y. V. Bayborodov, Jr.; Avastine Injections Into Sub-tenon’s Space Prior to Surgical Treatment for Diabetic Proliferative Retinopathy. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2729. doi: https://doi.org/.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To study effects of sub-Tenon’s injections of Avastive on course of neoangiogenesis and ability of Avastine to cause detachment of posterior hyaloid in complex surgical treatment of patients with diabetic proliferative retinopathy.
Twenty-eight eyes of fourteen patients diagnosed with type I diabetes mellitus and diabetic proliferative retinopathy in both eyes, underwent eye surgical treatment. Seven days prior to the surgery all patients received injection of Avastine, 5 mg, into sub-Tenon’s space. Surgical treatment included vitrectomy with posterior hyaloid membrane (PHM) removal. Pre- and post-operative methods of evaluation included fundoscopy, B-scanning, optical coherent tomography (OCT) and photography.
Significant regress of new vessels on PHM was observed within pre-operative week following Avastine injection in all patients. One week after the injection, fundoscopy, B-scan, OCT and photography revealed enlargement of macular edema area in patients with attached macula and increased retinal detachment height along with partial PHM detachment in patients with detached macula.Intra-operative bleeding during PHM peeling was avoided in 13 out of 14 patients.
Sub-Tenon’s injection of 5 mg Avastine one week prior to surgical treatment in patients with diabetic proliferative retinopathy results in significant regress of vitreoretinal neovascularization and induces PHM detachment.
This PDF is available to Subscribers Only